SOUTH PLAINFIELD, N.J. (AP) _ PTC Therapeutics Inc. (PTCT) on Monday reported a loss of $77.7 million in its fourth quarter.
On a per-share basis, the South Plainfield, New Jersey-based company said it had a loss of $1.37. Losses, adjusted for non-recurring costs, came to $1.15 per share.
The results fell short of Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of 53 cents per share.
The biopharmaceutical company posted revenue of $96.5 million in the period.
For the year, the company reported that its loss widened to $251.6 million, or $4.27 per share. Revenue was reported as $307 million.
PTC Therapeutics shares have climbed 14% since the beginning of the year. In the final minutes of trading on Monday, shares hit $54.93, a climb of 54% in the last 12 months.